We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.75B
Cap. Flow %
-19.89%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.76%
3 Healthcare 14.3%
4 Real Estate 8.12%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSPC
576
DELISTED
Post Holdings Partnering Corporation
PSPC
$2.27M 0.03%
233,953
-23,421
-9% -$228K
PICC
577
DELISTED
Pivotal Investment Corporation III
PICC
$2.26M 0.03%
229,322
-23,466
-9% -$231K
SHEL icon
578
Shell
SHEL
$245B
$2.25M 0.03%
45,303
-3,012
-6% -$155K
MTAL
579
DELISTED
Metals Acquisition
MTAL
$2.25M 0.03%
229,785
-23,003
-9% -$225K
DYN icon
580
Dyne Therapeutics
DYN
$4.9B
$2.24M 0.03%
176,490
-50,868
-22% -$583K
XLF icon
581
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$2.21M 0.03%
+1,200,000
New +$39.7M
FNVT
582
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.17M 0.02%
214,762
-21,499
-9% -$216K
DNAD
583
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.15M 0.02%
218,128
-21,836
-9% -$213K
TXNM
584
TXNM Energy Inc
TXNM
$5.94B
$2.14M 0.02%
+46,872
New +$2.23M
DY icon
585
Dycom Industries
DY
$12.3B
$2.14M 0.02%
22,377
+3,422
+18% +$358K
CITE
586
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.13M 0.02%
210,558
-21,079
-9% -$212K
DOC icon
587
Healthpeak Properties
DOC
$14.8B
$2.09M 0.02%
91,011
-139,174
-60% -$3.68M
ANAB icon
588
AnaptysBio
ANAB
$1.68B
$2.08M 0.02%
81,668
+702
+0.9% +$16.5K
RIG icon
589
PUT
Transocean
RIG
$5.82B
$2.07M 0.02%
1,967,700
ON icon
590
ON Semiconductor
ON
$19.3B
$2.04M 0.02%
+32,770
New +$2.11M
VLO icon
591
Valero Energy
VLO
$85.9B
$2.04M 0.02%
19,053
-1,253
-6% -$138K
MTRY
592
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$2.03M 0.02%
190,898
-19,111
-9% -$192K
O icon
593
Realty Income
O
$59.1B
$2.02M 0.02%
34,718
+10,597
+44% +$731K
GMFI
594
DELISTED
Aetherium Acquisition Corp
GMFI
$2.02M 0.02%
203,024
-157,300
-44% -$1.56M
SDGR icon
595
Schrodinger
SDGR
$1.36B
$1.99M 0.02%
79,547
+5,000
+7% +$147K
MRK icon
596
Merck
MRK
$318B
$1.96M 0.02%
+22,800
New +$2.04M
PTGX icon
597
Protagonist Therapeutics
PTGX
$9.44B
$1.96M 0.02%
232,820
+13,000
+6% +$123K
XENE icon
598
Xenon Pharmaceuticals
XENE
$6.12B
$1.96M 0.02%
54,208
-42,000
-44% -$1.51M
GFX
599
DELISTED
Golden Falcon Acquisition Corp.
GFX
$1.95M 0.02%
195,521
-19,656
-9% -$195K
IOVA icon
600
Iovance Biotherapeutics
IOVA
$2.83B
$1.94M 0.02%
202,872
-54,000
-21% -$623K

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.75B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.